GroPep infertility data presented at US meeting

GroPep's program to develop a treatment for infertility reached another milestone with the release of key data at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in the US. The data will be presented by a leading international researcher in infertility.

More than 50% of recurrent miscarriages have no apparent explanation* and the market for a drug to correct this is potentially worth up to US$750 million annually.

Following the success of pre-clinical studies performed at McMaster University in Canada, the GroPep drug is on track to be tested in Phase I trials during 2006.

A leading international infertility researcher, Professor David Clark, will present key pre-clinical data on GroPep's infertility drug, PV903, at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in Providence, Rhode Island, 16-18 June 2005.

Professor Clark's research found that administration of a single dose of the GroPep drug PV903 halved the miscarriage rate in a strain of female mice susceptible to the immune rejection of the foetus (a suspected major cause of recurrent miscarriage in women).

Scientists believe that women who suffer from repeated miscarriage have an immune system that attacks the embryo as "foreign" in the same way it would a virus or bacteria. The GroPep drug contains an active ingredient found in semen (called a "cytokine") that is thought to instruct the mother's immune system to "tolerate" the foetus.

Professor Clark, who was President of the American Society for Reproductive Immunology between 1996 and 1998, said: "This is the first time a cytokine has been shown to positively affect reproductive outcome in an animal model of reproductive failure that shares many pathological features with recurrent miscarriage in humans. Clinical trials in women with a history of recurrent miscarriage are warranted."

He further noted that: "Past advances in endo

Contact: Mr Tony Mitchell
Research Australia

Page: 1 2

Related biology news :

1. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Male or female factor infertility -- men suffer just the same
4. Risk-taking in infertility treatment correlates with womens negative moods
5. New research holds promise for protecting cancer patients against infertility
6. Stressed-out African naked mole-rats may provide clues about human infertility
7. Key to male infertility
8. Researchers find gene mutation that causes infertility in male mice
9. Treating male infertility with stem cells
10. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
11. World-first stem cell research could aid male infertility

Post Your Comments:

(Date:11/27/2019)... ... ... Though the forecast for the Thanksgiving holiday might look a bit grim, ... the roads and the skies. It’s a new personal recipe organizer app called MINE ... simple design, mouth-watering pictures of food, an optional social component and an easy-to-navigate recipe ...
(Date:11/22/2019)... ... 21, 2019 , ... The inventors of a new and ... major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert ... from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... The inaugural ... Times Square in New York City. The one-day event will be chaired by Dr ... of leaders in the space. , “We are witnessing significant innovation in cell ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 17, 2019 , ... ... is pleased to announce that it has hired Dr. Alia Orbin, Ph.D., ... Orbin is experienced in the preparation, filing and prosecution of patent applications related ...
(Date:12/4/2019)... ... 03, 2019 , ... A new survey by MedReps ( http://www.medreps.com ), a ... overall best medical sales companies to work for in 2020. , The ... professionals from the MedReps community to identify which medical sales companies are currently the ...
(Date:12/4/2019)... Indiana (PRWEB) , ... December 04, 2019 , ... ... strategy to further enhance dissolution and stabilize amorphous materials. Additionally, their PDF Synchrotron ... enhance the ability to describe these compositions both in regulatory and patent applications.  ...
(Date:11/22/2019)... (PRWEB) , ... November 22, ... ... chain engineering firm, hosted a live webinar covering a step-by-step cold chain ... antibodies, antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry ...
Breaking Biology Technology:
Cached News: